Skip to main content

ADVERTISEMENT

second-generation drug-eluting stent

Original Contribution
06/15/2017

Björn Redfors, MD, PhD1;  Akiko Maehara, MD1,2;  Bernhard Witzenbichler, MD3;  Giora Weisz, MD1,2,4;  Thomas D. Stuckey, MD5;  Timothy D. Henry, MD6,7;  Thomas McAndrew, PhD1;  Roxana Mehran, MD1,8;  Ajay J. Kirtane, MD, SM1,2;  Gregg W. Stone, MD1,2;  Philippe Généreux, MD1,9,10

Björn Redfors, MD, PhD1;  Akiko Maeha...
We report the adverse event rates after rotational atherectomy (RA) with contemporary drug-eluting stent implantation and compare RA to cutting balloon angioplasty and balloon-only angioplasty in the all-comers ADAPT-DES trial.
We report the adverse event rates after rotational atherectomy (RA) with contemporary drug-eluting stent implantation and compare RA to cutting balloon angioplasty and balloon-only angioplasty in the all-comers ADAPT-DES trial.
We report the adverse event...
06/15/2017
Journal of Invasive Cardiology